Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer

  • Authors:
    • M. O. Hoque
    • H. Kawamata
    • K.-I. Nakashiro
    • F. Omotehara
    • Y. Shinagawa
    • S. Hino
    • N.-M. Begum
    • D. Uchida
    • H. Yoshida
    • M. Sato
    • T. Fujimori
  • View Affiliations

  • Published online on: November 1, 2001     https://doi.org/10.3892/ijo.19.5.953
  • Pages: 953-958
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The measurement of the intra-tumoral level of thymidylate synthetase (TS), and dihydropyrimidine dehydrogenase (DPD), may be useful in predicting tumor sensitivity to 5-fluorouracil (5-FU). In this study, we examined the mRNA levels of DPD and TS in 28 oral squamous cell carcinomas (SCC), and 22 salivary gland tumors by semi-quantitative reverse transcription polymerase chain reaction. Then we examined the correlation of the responsiveness of the patients with oral SCC to 5-FU with the intra-tumoral levels of DPD and TS mRNA. All specimens were obtained at the biopsy before treatment, and then the patients were treated by oral administration of a 5-FU compound (UFT), the irradiation of cobalt-60 (upto 60 Gy) and injection of an immuno-potentiator (OK-432). Intra-tumoral levels of DPD mRNA in the patients who showed CR (complete response) and PR (partial response) were significantly lower than those in the patients who showed NC (no change). However, intra-tumoral levels of DPD mRNA did not correlate with the local recurrence of the tumor during the observation period after initial treatment with or without surgical resection of the residual tumors. On the other hand, TS mRNA levels in the tumors did not correlate with any clinico-pathological parameters. These observations suggest that intra-tumoral levels of DPD mRNA may predict the tumor response to 5-FU-based chemo-immuno-radiation therapy in the patients with oral SCC.

Related Articles

Journal Cover

November 2001
Volume 19 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hoque MO, Kawamata H, Nakashiro K, Omotehara F, Shinagawa Y, Hino S, Begum N, Uchida D, Yoshida H, Sato M, Sato M, et al: Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer. Int J Oncol 19: 953-958, 2001
APA
Hoque, M.O., Kawamata, H., Nakashiro, K., Omotehara, F., Shinagawa, Y., Hino, S. ... Fujimori, T. (2001). Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer. International Journal of Oncology, 19, 953-958. https://doi.org/10.3892/ijo.19.5.953
MLA
Hoque, M. O., Kawamata, H., Nakashiro, K., Omotehara, F., Shinagawa, Y., Hino, S., Begum, N., Uchida, D., Yoshida, H., Sato, M., Fujimori, T."Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer". International Journal of Oncology 19.5 (2001): 953-958.
Chicago
Hoque, M. O., Kawamata, H., Nakashiro, K., Omotehara, F., Shinagawa, Y., Hino, S., Begum, N., Uchida, D., Yoshida, H., Sato, M., Fujimori, T."Dihydropyrimidine dehydrogenase mRNA level correlates with the response to 5-fluorouracil-based chemo-immuno-radiation therapy in human oral squamous cell cancer". International Journal of Oncology 19, no. 5 (2001): 953-958. https://doi.org/10.3892/ijo.19.5.953